Back
United Therapeutics Stock Price Chart
Yours Free! Top SIX AI Dividend Stocks Right Now
NO CREDIT CARD REQUIRED!
Buy
60
UTHR
United Therapeutics
Last Price:
397.46
Seasonality Move:
4.71%
7 Day Trial
ALL ACCESS PASS
$
7
The Mysterious VC Firm Behind Nvidia's Secret Weapon
Details Here!- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and UTHR is experiencing buying pressure, which is a positive indicator for future bullish movement.
United Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 364.96 | Buy |
| 20-day SMA: | 362.15 | Buy |
| 50-day SMA: | 355.84 | Buy |
| 200-day SMA: | 290.79 | Buy |
| 8-day EMA: | 369.93 | Buy |
| 20-day EMA: | 363.35 | Buy |
| 50-day EMA: | 353.96 | Buy |
| 200-day EMA: | 306.64 | Buy |
United Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 5.45 | Buy |
| Relative Strength Index (14 RSI): | 68.39 | Buy |
| Chaikin Money Flow: | 267752 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (350.62 - 370.1) | Buy |
| Bollinger Bands (100): | (320.79 - 359.69) | Buy |
United Therapeutics Technical Analysis
| Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for United Therapeutics Stock
Is United Therapeutics Stock a Buy?
- United Therapeutics share price is 382.77 while UTHR 8-day simple moving average is 364.96, which is a Buy signal.
- The stock price of UTHR is 382.77 while United Therapeutics 20-day SMA is 362.15, which makes it a Buy.
- United Therapeutics 50-day simple moving average is 355.84 while UTHR share price is 382.77, making it a Buy technically.
- UTHR stock price is 382.77 and United Therapeutics 200-day simple moving average is 290.79, creating a Buy signal.
UTHR Technical Analysis vs Fundamental Analysis
Buy
60
United Therapeutics (UTHR)
is a Buy
Is United Therapeutics a Buy or a Sell?
-
United Therapeutics stock is rated a Buy
The current United Therapeutics [UTHR] share price is $382.77. The Score for UTHR is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
United Therapeutics Stock Info
Market Cap:
17.09B
Price in USD:
382.77
Share Volume:
277.84K
United Therapeutics 52-Week Range
52-Week High:
382.95
52-Week Low:
208.62
Buy
60
United Therapeutics (UTHR)
is a Buy
United Therapeutics Share Price Forecast
-
What is the United Therapeutics stock price today?
The United Therapeutics stock price is 382.77 USD today. -
Will UTHR stock go up or go down?
United Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is United Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, United Therapeutics is not overvalued.
Is United Therapeutics Stock a Buy?
- United Therapeutics share price is 382.77 while UTHR 8-day exponential moving average is 369.93, which is a Buy signal.
- The stock price of UTHR is 382.77 while United Therapeutics 20-day EMA is 363.35, which makes it a Buy.
- United Therapeutics 50-day exponential moving average is 353.96 while UTHR share price is 382.77, making it a Buy technically.
- UTHR stock price is 382.77 and United Therapeutics 200-day simple moving average is 306.64, creating a Buy signal.
Fundamental Analysis of United Therapeutics
Is United Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $1.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $6.10 per share, and an increase next year of $2.37 per share.
Technical Analysis of United Therapeutics
Should I short United Therapeutics stock?
- UTHR Moving Average Covergence Divergence (MACD) indicator is 5.45, suggesting United Therapeutics is a Buy
- United Therapeutics Relative Strength Index (RSI) is 68.39, which suggest United Therapeutics is overbought
- The Bollinger Bands (25) for United Therapeutics is (350.62 - 370.1), which suggest United Therapeutics is a Buy
- The Bollinger Bands (100) for United Therapeutics is (320.79 - 359.69), which suggest United Therapeutics is a Buy
* United Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.